StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AKAN

Akanda Corp.

AKAN Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗
$2.57
-0.26 -9.03%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$5.10M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$2.30 – $209.23

AI briefing

from the latest 10-K, 10-Q and 8-K events

Akanda Corp. is a Canadian-incorporated, Nasdaq-listed company that filed its annual report on Form 20-F for fiscal year 2025.

What they do

Akanda Corp. was incorporated in Ontario, Canada on July 16, 2021. Its common shares trade on The Nasdaq Capital Market under the symbol "AKAN." Based on the excerpt provided, the filing confirms the company's incorporation, listing and reporting status but does not describe its operating business, products or segments.

Revenue drivers

  • Not disclosed in provided excerpt — The excerpt does not identify any business segments, product lines, customers or revenue sources.

Recent performance

The provided excerpt contains no financial results. It states only that the number of common shares outstanding as of December 31, 2025 was 1,983,546. No revenue, expense, profit or loss figures are included in the material supplied.

Strategy

No strategy discussion appears in the provided excerpt. The excerpt consists of the Form 20-F cover page, table of contents and introductory language. It notes that financial statements are prepared under IFRS as issued by the IASB, with a fiscal year ending December 31.

Risks

  • Incomplete source material — The excerpt provided does not include Item 3.D Risk Factors, so company-specific risks cannot be summarized from the available text.
  • Foreign private issuer reporting — As a Canadian issuer filing on Form 20-F, Akanda reports under a different regime and timeline than U.S. domestic filers, which may affect information availability for U.S. investors.
  • Nasdaq listing — The company's common shares are listed solely on The Nasdaq Capital Market under the symbol "AKAN," concentrating trading and liquidity in one venue.
  • Small public float — With 1,983,546 common shares outstanding as of December 31, 2025, the company has a very small share count, which can accompany limited liquidity and price volatility.

Outlook

The provided excerpt contains no management outlook or forward guidance. It does not include MD&A discussion or trend information. No statements about future plans, investments or priorities are available in the material supplied.

Recent SEC filings

40 most recent
Annual, quarterly & current reports